Clinical Trial Update: Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation [Phase 1]

View source ↗

Summary

A Phase 1 trial of Afatinib in combination with cisplatin or carboplatin plus pemetrexed for EGFR-mutant non-small cell lung cancer undergoing definitive chemor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Afatinib (afatinib)
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: WITHDRAWN